louisiana glp-1 nausea lawsuit Risks of Ozempic, other drugs are at center of sweeping that kicked off in Philadelphia Louisiana's Best Virtual Weight Loss
Description
Mounjaro is not unique
pink label (0.5 mg dose)
Alabamas contributory negligence rule is rarely a barrier in GLP-1 cases because liability centers on manufacturer failures to adequately warn patients of known gastrointestinal risks
At the 2025 Heart Rhythm Society annual meeting, Sundaram and colleagues presented the results of the TRANSFORM-AF trial
Common GI side effects like nausea, diarrhea, and abdominal pain tend to be mild and manageable
The concept of microdosing typically involves starting with doses as low as 0.5 mg to 1.25 mg weekly, which are fractions of the approved 2.5 mg starting dose
